Endocrinology, Diabetes & Metabolism Doctors in Pueblo, CO Accepting Medicare

5 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 5

Dr. William Albert Gonzales Jr., MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4112 Outlook Blvd, Pueblo, CO 81008 Phone: 719-553-1000

Ana Maria Ramirez Berlioz, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4722 Eagleridge Cir, Pueblo, CO 81008 Phone: 719-595-7563    Fax: 719-595-7907

Agha Baber Khan, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1303 Fortino Blvd Ste A, Pueblo, CO 81008 Phone: 719-544-0052

Robert Nichols Alsever, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1600 North Grand Avenue, Suite 150, Pueblo, CO 81003 Phone: 719-595-7563    Fax: 719-595-7907

Kenneth D Dernovsek, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1925 E Orman Ave, Ste 115, Pueblo, CO 81004 Phone: 719-564-4500    Fax: 719-564-0304

News Archive

KAI enters KAI-4169 development and commercialization agreement with Ono

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the development and commercialization in Japan of KAI-4169, KAI's lead product candidate.

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

Insuring your health: Health law requires continued coverage for patients in clinical trials

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "When Richard Crusoe was diagnosed with a rare form of soft tissue cancer called liposarcoma, the retired firefighter and his family pinned their hopes of slowing the cancer's advance on a drug that was being tested in a clinical trial" (Andrews, 8/24).

Integrated Research Network to analyze payor health policy for chronic pain medications

HealthCore's Integrated Research Network is enrolling family physicians, general practitioners, internists, neurologists, rheumatologists, endocrinologists, and pain management specialists in a first-of-its-kind study to analyze payor health policy for chronic pain medications.

Cell Therapeutics Board approves reverse stock split

Cell Therapeutics, Inc. today announced that the Company's Board of Directors approved a reverse stock split following the Company's receipt on May 3, 2011 of a notification of non-compliance from the staff of The NASDAQ Stock Market LLC.

Read more Medical News

› Verified 1 days ago